XJPX7679
Market cap244mUSD
Dec 24, Last price
1,961.00JPY
1D
0.62%
1Q
-22.18%
IPO
-20.45%
Name
Yakuodo Holdings Co Ltd
Chart & Performance
P/E
10.05
P/S
0.27
EPS
195.20
Div Yield, %
1.27%
Shrs. gr., 5y
-0.15%
Rev. gr., 5y
9.15%
Revenues
142.24b
+10.44%
Net income
3.83b
+18.06%
CFO
5.63b
-12.14%
Dividend
Feb 27, 202527 JPY/sh
Earnings
Jan 03, 2025
Profile
YAKUODO HOLDINGS Co., Ltd., through its subsidiaries, engages in the management of drug stores in Japan. It operates 358 stores. The company was founded in 1978 and is headquartered in Morioka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | 2016‑02 | |
| Income | |||||||||
Revenues | 142,241,000 10.44% | 128,791,000 7.05% | 120,310,000 8.84% | ||||||
Cost of revenue | 114,380,000 | 100,543,000 | 93,072,000 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 27,861,000 | 28,248,000 | 27,238,000 | ||||||
NOPBT Margin | 19.59% | 21.93% | 22.64% | ||||||
Operating Taxes | 1,467,000 | 1,481,000 | 1,078,000 | ||||||
Tax Rate | 5.27% | 5.24% | 3.96% | ||||||
NOPAT | 26,394,000 | 26,767,000 | 26,160,000 | ||||||
Net income | 3,825,000 18.06% | 3,240,000 9.31% | 2,964,000 -9.91% | ||||||
Dividends | (489,000) | (473,000) | (454,000) | ||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 2,527,000 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 2,643,000 | 3,144,000 | 3,146,000 | ||||||
Long-term debt | 13,571,000 | 14,433,000 | 13,834,000 | ||||||
Deferred revenue | (297,000) | (290,000) | |||||||
Other long-term liabilities | 1,977,000 | 1,917,000 | 1,806,000 | ||||||
Net debt | 7,844,000 | 8,680,000 | 9,166,000 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 5,628,000 | 6,406,000 | 3,690,000 | ||||||
CAPEX | (2,043,000) | (3,710,000) | (6,183,000) | ||||||
Cash from investing activities | (2,268,000) | (4,106,000) | (6,625,000) | ||||||
Cash from financing activities | (3,688,000) | (1,274,000) | (1,946,000) | ||||||
FCF | 26,821,000 | 22,303,000 | 19,660,000 | ||||||
| Balance | |||||||||
Cash | 4,952,000 | 5,280,000 | 4,255,000 | ||||||
Long term investments | 3,418,000 | 3,617,000 | 3,559,000 | ||||||
Excess cash | 1,257,950 | 2,457,450 | 1,798,500 | ||||||
Stockholders' equity | 31,302,000 | 27,954,000 | 25,226,000 | ||||||
Invested Capital | 47,628,050 | 43,744,550 | 42,248,500 | ||||||
ROIC | 57.77% | 62.25% | 68.18% | ||||||
ROCE | 56.99% | 60.75% | 61.43% | ||||||
| EV | |||||||||
Common stock shares outstanding | 19,595 | 19,646 | 19,740 | ||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 30,680,000 | 31,050,000 | 29,829,000 | ||||||
EV/EBITDA | |||||||||
Interest | 48,000 | 38,000 | 31,000 | ||||||
Interest/NOPBT | 0.17% | 0.13% | 0.11% | ||||||